Grail ACQUIRED:ILMN | PUBLIC Breakthrough pan-cancer screening test using genomics https://grail.com/ Press Releases GRAIL Appoints Gautam Kollu as Chief Commercial Officer Dec 16, 2019 GRAIL Announces Positive Validation Data for its Multi-Cancer Early Detection Test Oct 7, 2019 GRAIL Appoints Matthew Young as Chief Operating Officer and Chief Financial Officer Oct 7, 2019 GRAIL Appoints Marissa Song as General Counsel and Corporate Secretary Sep 30, 2019 CRISPR-Chip Moves One Step Closer to the Genomics Market Sep 6, 2019 GRAIL Appoints Rodger Currie as Head of Government Affairs and Alliance Development Aug 25, 2019 GRAIL Announces Appointment of Hans Bishop as Chief Executive Officer and Strengthens Leadership Team and Board of Directors with New Appointments Jun 6, 2019 GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study May 31, 2019 GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at 2019 American Society of Clinical Oncology Annual Meeting May 15, 2019 GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation May 13, 2019 Press Coverage About Grail Stays at Forefront of Liquid Biopsy Conversation with New Results Oct 10, 2019 Healthcare Finance: The Top 25 Voices in Precision Medicine announced by BIS Research May 22, 2019
GRAIL Announces Appointment of Hans Bishop as Chief Executive Officer and Strengthens Leadership Team and Board of Directors with New Appointments Jun 6, 2019
GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study May 31, 2019
GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at 2019 American Society of Clinical Oncology Annual Meeting May 15, 2019
GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation May 13, 2019
